7-(S)-(L-alaninyl)-amino-5-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 7-(S)-(L-alaninyl)-amino-5-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one
• 英文别名: (S)-2-amino-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide；(2S)-2-amino-N-[(7S)-5-methyl-6-oxo-7H-benzo[d][1]benzazepin-7-yl]propanamide
• 化学式: C₁₈H₁₉N₃O₂
• 分子量: 309.368
• InChiKey: OSDQYEDPZCYWRA-ZBEGNZNMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  75.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-(S)-(L-alaninyl)-amino-5-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one 、 L-α-羟基异戊酸 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 20.0h， 生成 7-(S)-(N'-((S)-(+)-2-hydroxy-3-methylbutyryl)-L-alaninyl)amino-5-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one
  参考文献：
  名称：

  CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS

  摘要：

  公开号：

  EP0951466B1
• 作为产物：
  描述：

  ((S)-1-(((S)-5-甲基-6-氧代-6,7-二氢-5H-二苯并[B,D]氮杂-7-基) 在 盐酸 作用下， 以 乙酸乙酯 为溶剂， 生成 7-(S)-(L-alaninyl)-amino-5-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one
  参考文献：
  名称：

  γ-分泌酶抑制剂LY411575及其非对映异构体的多克化学合成。

  摘要：

  N-2（（2S）-2-（3,5-二氟苯基）-2-羟基乙酰基）-N1-（（7S）-5-甲基-6-氧代-6,7-二氢-描述了一种已知的γ-分泌酶抑制剂5H-二苯并[b，d] a庚啉-7-基）-1-丙氨酰胺（LY411,575，9a）。在整个序列中不使用手性色谱的关键合成步骤涉及（1）改进微波辅助合成的七元内酰胺（+/-）-（5,7-dihydro-6H-dibenz- [b， d）azepin-6-1 2和（2）通过简单的快速硅胶色谱法从四种非对映异构体的混合物中方便地分离出纯LY411575，从拆分的氨基内酰胺5a和5b开始，所有四种非对映异构体均以对映体纯的形式产生。

  DOI：

  10.1016/j.bmcl.2007.07.062

文献信息

• TREATING HEARING LOSS
  申请人：Massachusetts Eye & Ear Infirmary

  公开号：EP2892506A1

  公开（公告）日：2015-07-15
• PRODUCTION OF DIFFERENTIATED ENTEROENDOCRINE CELLS AND INSULIN PRODUCING CELLS
  申请人：Massachusetts Institute Of Technology

  公开号：EP3400286A1

  公开（公告）日：2018-11-14
• [EN] TREATING HEARING LOSS<br/>[FR] TRAITEMENT DE LA PERTE AUDITIVE
  申请人：MASSACHUSETTS EYE & EAR INFIRM

  公开号：WO2014039781A1

  公开（公告）日：2014-03-13

  This invention relates to methods for treating hearing loss associated with loss of cochlear hair cells, e.g., caused by noise exposure, using certain gamma secretase inhibitors, in post-neonatal animals, e.g., adolescents and adults.
• [EN] PRODUCTION OF DIFFERENTIATED ENTEROENDOCRINE CELLS AND INSULIN PRODUCING CELLS<br/>[FR] PRODUCTION DE CELLULES ENTÉROENDOCRINES DIFFÉRENCIÉES ET CELLULES PRODUISANT DE L'INSULINE
  申请人：MASSACHUSETTS INST TECHNOLOGY

  公开号：WO2017120543A1

  公开（公告）日：2017-07-13

  A population of enteroendocrine cells (EEC) is obtained from a mammalian post-natal cell population, such as a population including post-natal stem cells, by treating the population with a plurality of small molecules that upregulate ChgA and promote differentiation of the cells to form the enteroendocrine cells. The upregulation of ChgA is such that the fraction of cells expressing CGA in the obtained cell population, as measured by a ChgA Immunostaining Assay, is at least about 1.5%. Small molecules that can be used to differentiate the post-natal cells into the enteroendocrine cells can include at least one of a Wnt activator, a Notch inhibitor, a Wnt inhibitor, a MEK/ERK inhibitor, a growth factor, a HDAC inhibitor, a Histone Methylation Inhibitor, a Tgf-β inhibitor, and a NeuroD1 activator. Also, the insulin expression of a population of mammalian cells is increased by treating the population with a plurality of small molecules that increase the insulin expression.
• CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
  申请人：ELAN PHARMACEUTICALS, INC.

  公开号：EP0951466B1

  公开（公告）日：2009-01-21